-
DiscoveryJul 15, 2021Investigating the myopia mysteryTwo scientists from Basel are trying to shed light on why myopia is impacting more and more people.
Discovery -
DiscoverySep 27, 2021Cancer research drives breast cancer treatment forwardNovartis team perseveres to develop more personalized approach to breast cancer therapy.
Discovery -
DiscoveryJul 19, 2021Respiratory clinical trials: Putting patients at the heart of researchAll treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.
Discovery -
DiscoveryJul 19, 2021Women in Science: Sandrine Piret-GérardSandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.
Discovery -
Access to HealthcareJul 20, 2021Asian health experts call for final push to wipe out deadliest form of malariaThe most lethal strain could be eliminated by 2030, but major hurdles remain.
Access to Healthcare -
Jul 14, 2021Counting on combos for complex liver diseasesThe best treatment for multifaceted diseases like NASH may be combinations of drugs.
-
Jul 12, 2021Bringing gene therapy into focusDr. Botond Roska says we should keep our eyes on gene therapy.
-
From Our LabsJul 20, 2021What goes wrong with the window to the soul in glaucoma?Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
From Our Labs -
DiscoveryJul 14, 2021Experimental gene therapy discovered in-house enters clinical testingNovartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.
Discovery -
DiscoveryJul 19, 2021Visualizing immuno-oncology researchLearn how Novartis researchers are working to outsmart tumors.
Discovery -
People and CultureAug 10, 2021Enabling 130,000 employees to grow in an organization committed to continuous learningOur Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.
People and Culture -
Access to HealthcareAug 11, 2021Novartis Access impact evaluation: progress update on our work with Boston UniversityBoston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
Access to Healthcare